NCT04047433

Brief Summary

Single-nucleotide polymorphisms (SNP's) in connective tissue components are associated with increased risk of pelvic organ prolapse (POP). The investigators expect to find a difference in SNP's frequency between women who had Obstetric anal sphincter injuries (OASIS) and in the healthy population. The fact that pelvic organ prolapse (POP) and OASIS occurs in the same anatomic region and the well-known association between few SNP's and the risk for POP, suggests for a common pathophysiology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 6, 2019

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 4, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2023

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

August 2, 2019

Last Update Submit

March 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • difference in the frequency of of Single-nucleotide polymorphisms

    difference in the relative frequency of Single-nucleotide polymorphisms between women with external anal sphincter injury that occurs during vaginal delivery and those without it.

    through study completion, an average of 2 years

Secondary Outcomes (1)

  • genetic mutation

    through study completion, an average of 2 years

Study Arms (2)

women with external anal sphincter injury

EXPERIMENTAL

The study cohort will be composed of women undergoing vaginal delivery and diagnosed with external anal sphincter injury after a vaginal delivery.

Genetic: screening for single nucleotide polymorphismGenetic: whole exome sequencing

women without external anal sphincter injury

EXPERIMENTAL

The control group will be women who had a vaginal delivery without any clinically apparent perineal laceration

Genetic: screening for single nucleotide polymorphism

Interventions

samples from both arms will be tested for a set of single nucleotide polymorphism

women with external anal sphincter injurywomen without external anal sphincter injury

samples from arm #1 (women with external anal sphincter) will be tested for identifying specific genetic mutation

women with external anal sphincter injury

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women with severe external anal sphincter injury during first vaginal delivery
  • Healthy women undergoing vaginal delivery without any clinically apparent perineal laceration

You may not qualify if:

  • Women with known metabolic or connective-tissue disorder (e.g., Ehlers-Danlos syndrome).
  • Women with known neurologic disorder
  • Women undergoing episiotomy cut or assisted delivery (e.g., vacuum or forceps delivery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haemek Medical Center

Afula, Israel, Israel

Location

MeSH Terms

Interventions

Mass ScreeningPolymorphism, Single NucleotideExome Sequencing

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health PracticePolymorphism, GeneticGenetic VariationGenetic PhenomenaWhole Genome SequencingSequence Analysis, DNASequence AnalysisGenetic Techniques

Study Officials

  • Hedi Raischer, MD

    haemek medical center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: two arms - 1. with external anal sphincter injury 2. without injury both will go through genetic screening test the arm with the external anal sphincter injury will also be tested for advanced genetic testing
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 2, 2019

First Posted

August 6, 2019

Study Start

September 4, 2020

Primary Completion

October 5, 2023

Study Completion

October 5, 2023

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations